Osteogenic Induction of Low-dose Ipriflavone on Bone Marrow Mesenchymal Stem Cells Extracted from Osteoporosis Rats

Chin J Dent Res. 2021 Sep 7;24(3):153-158. doi: 10.3290/j.cjdr.b1965039.

Abstract

Objective: To investigate the effects of ipriflavone (IPF), a synthetic isoflavone plant oestrogen with a structure similar to that of oestradiol, on the osteogenic differentiation of bone mesenchymal stem cells (BMSCs).

Methods: BMSCs were derived from ovariectomised rats (rBMSCs-OVX) and then induced with or without IPF. Cell cytotoxicity, mineralisation in vitro and osteoblast-specific gene expression of BMSCs were studied.

Results: IPF at a concentration of 10-8, 10-7 and 10-6 mol/l exhibited no cytotoxic effect on the proliferation of BMSCs but increased alkaline phosphatase activity and osteoblast-specific gene expression.

Conclusion: IPF enhances osteogenic differentiation of rBMSCs-OVX partly in vitro, thus its use offers a potential strategy for the treatment of osteoporosis.

Keywords: ipriflavone; mesenchymal stem cells; osteogenic differentiation; osteoporosis.

MeSH terms

  • Animals
  • Cells, Cultured
  • Isoflavones* / pharmacology
  • Mesenchymal Stem Cells*
  • Osteogenesis
  • Osteoporosis* / drug therapy
  • Rats

Substances

  • Isoflavones
  • ipriflavone